Literature DB >> 21380506

Local calprotectin production in colorectal cancer and polyps--active neutrophil recruitment in carcinogenesis.

Kim Luley1, Frank Noack, Hendrik Lehnert, Nils Homann.   

Abstract

AIM: The aim of this study is to examine the expression level and localization of calprotectin in cancer tissue, tumor-adjacent mucosa, and polyps in colonic biopsies. Calprotection expression was correlated with neutrophil infiltration, markers of bacteremia, and systemic inflammation.
MATERIALS AND METHODS: Patients with colorectal cancer (n = 28) and adenoma (n = 38) were compared with healthy controls (n = 33). Calprotectin expression levels were measured by ELISA, and its localization was visualized by immunohistochemistry and correlated with the degree of neutrophil infiltration (visualized by Esterase staining). The expression of tumor necrosis factor (TNF)-alpha, procalcitonin, endotoxemia, carcinoembryonic antigen (CEA), and C-reactive protein was also investigated.
RESULTS: Mucosal calprotectin was expressed in significantly higher concentrations in carcinoma (94.2 ± 31.2 ng/mg total protein) and adenoma (122.8 ± 60.3 ng/mg total protein) in comparison with mucosal biopsies from healthy controls (20.4 ± 5.4 ng/mg total protein), tumor-adjacent mucosa from patients with colorectal carcinoma (21.6 ± 5.1 ng/mg total protein), and adenoma (45 ± 14.6 ng/mg total protein, all p < 0.05). Immunohistochemistry showed calprotectin reactivity mainly in granulocytes and macrophages with only singular reactive epithelial cells. Positive staining (quantified by the number of positive cells per square millimeter) was markedly increased in carcinoma tissue (85 ± 21.5) and in adenoma (67.5 ± 20) as compared with tumor-adjacent epithelia (18.8 ± 4.3, p = 0.0007, p = 0.003, respectively), and there was a highly significant correlation, r = 0.89, p = 0.001) between calprotectin staining and neutrophil infiltration. No significant differences were found in the systemic levels of TNF-alpha, procalcitonin, and endotoxemia, whereas CEA and C-reactive protein levels were significantly higher in the cancer group (p < 0.05).
CONCLUSION: Our results support the evidence that increased calprotectin expression is an early step in the neoplastic transformation during colorectal carcinogenesis. Moreover, its expression is closely related to an inflammatory response and points out a possible biological link between inflammation and neoplastic transformation in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380506     DOI: 10.1007/s00384-011-1165-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  18 in total

Review 1.  Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity.

Authors:  Satoru Yui; Yuichi Nakatani; Masaaki Mikami
Journal:  Biol Pharm Bull       Date:  2003-06       Impact factor: 2.233

Review 2.  Emerging role of calprotectin in gastroenterology.

Authors:  Andrew Poullis; Russell Foster; Michael A Mendall; Magne K Fagerhol
Journal:  J Gastroenterol Hepatol       Date:  2003-07       Impact factor: 4.029

3.  Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin.

Authors:  I Dale; P Brandtzaeg; M K Fagerhol; H Scott
Journal:  Am J Clin Pathol       Date:  1985-07       Impact factor: 2.493

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Faecal calprotectin levels in a high risk population for colorectal neoplasia.

Authors:  O Kronborg; M Ugstad; P Fuglerud; B Johne; J Hardcastle; J H Scholefield; K Vellacott; V Moshakis; J R Reynolds
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 6.  Inflammation and cancer: how hot is the link?

Authors:  Bharat B Aggarwal; Shishir Shishodia; Santosh K Sandur; Manoj K Pandey; Gautam Sethi
Journal:  Biochem Pharmacol       Date:  2006-08-04       Impact factor: 5.858

7.  Calcium-dependent secretion in human neutrophils: a proteomic approach.

Authors:  M Boussac; J Garin
Journal:  Electrophoresis       Date:  2000-02       Impact factor: 3.535

8.  Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.

Authors:  Alexander C von Roon; Leonidas Karamountzos; Sanjay Purkayastha; George E Reese; Ara W Darzi; Julian P Teare; Paraskevas Paraskeva; Paris P Tekkis
Journal:  Am J Gastroenterol       Date:  2007-02-23       Impact factor: 10.864

9.  Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study.

Authors:  Gianmichele Meucci; Renata D'Incà; Roberto Maieron; Nicoletta Orzes; Maurizio Vecchi; Daniela Visentini; Giorgio Minoli; Elisabetta Dal Pont; Maurizio Zilli; Elvio Benedetti; Tiziana Virgilio; Elio Tonutti
Journal:  Dig Liver Dis       Date:  2009-08-19       Impact factor: 4.088

10.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

Authors:  Arlette Darfeuille-Michaud; Jérôme Boudeau; Philippe Bulois; Christel Neut; Anne-Lise Glasser; Nicolas Barnich; Marie-Agnès Bringer; Alexander Swidsinski; Laurent Beaugerie; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

View more
  7 in total

1.  Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.

Authors:  Frank Serge Lehmann; Francesca Trapani; Ida Fueglistaler; Luigi Maria Terracciano; Markus von Flüe; Gieri Cathomas; Andreas Zettl; Pascal Benkert; Daniel Oertli; Christoph Beglinger
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

2.  Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.

Authors:  Eva Peterova; Jan Bures; Paula Moravkova; Darina Kohoutova
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

Review 3.  Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy.

Authors:  Wei Zheng; Jingjing Wu; Yao Peng; Jing Sun; Pu Cheng; Qi Huang
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

4.  Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.

Authors:  Biao Fan; Lian-Hai Zhang; Yong-Ning Jia; Xi-Yao Zhong; Yi-Qiang Liu; Xiao-Jing Cheng; Xiao-Hong Wang; Xiao-Fang Xing; Ying Hu; Ying-Ai Li; Hong Du; Wei Zhao; Zhao-Jian Niu; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

5.  Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?

Authors:  M H McLean; A J Thomson; G I Murray; N Fyfe; G L Hold; E M El-Omar
Journal:  Br J Cancer       Date:  2013-06-04       Impact factor: 7.640

6.  Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.

Authors:  Luz María Medrano; Carlos Taxonera; Cristina González-Artacho; Virginia Pascual; María Gómez-García; Manuel Barreiro-de Acosta; José L Pérez-Calle; Fernando Bermejo; Antonio López-Sanromán; Dolores Martín Arranz; Javier P Gisbert; Juan Luis Mendoza; Javier Martín; Concepción Núñez; Elena Urcelay
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

7.  Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response.

Authors:  Yusuf Sahin; Ugur Yucetas; Huseyin Aytaç Ates; Erkan Erkan; Esma Yucetas; Mustafa Zafer Temiz; Mahmut Gokhan Toktas; Mustafa Kadihasanoglu; Birsen Cigdem Topkaya
Journal:  Investig Clin Urol       Date:  2019-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.